Medical Facility of the Future Coming to Clifton Park, NY

NEXT STORY
Innovation Pharmaceuticals Announces Successful Formulation of Oral Brilacidin Tablets; Upcoming Clinical Trial to Target Delivery to the Colon
PREV STORY
Peer-Reviewed Journal Future Oncology Publishes Two Manuscripts on Cancer Metabolism and Drug Candidate CPI-613® (Devimistat)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TG Therapeutics, Inc. Appoints Adam Waldman as Chief Commercial Officer

NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced ...

author_avatar
NASDAQ Market News

OncoMed Announces Publication of Phase 1a Data of Navicixizumab

Objective Responses Observed in Heavily-pretreated Ovarian Cancer Patients Treated with Navicixzumab MonotherapyREDWOOD CITY, Calif., ...

author_avatar
NASDAQ Market News

Abiomed Surpasses 50,000 Impella® Patients Treated in the United States

DANVERS, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider ...

author_avatar
NASDAQ Market News